Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience

被引：10

作者：

Memoli, Mara ^{[1
,2
]}

Paviglianiti, Annalisa ^{[1
]}

Malard, Florent ^{[1
,3
,4
]}

Battipaglia, Giorgia ^{[1
,4
]}

Brissot, Eolia ^{[1
,3
,4
]}

Mediavilla, Clemence ^{[1
,4
]}

Bianchessi, Antonio ^{[1
,5
]}

Banet, Anne ^{[1
]}

Van de Wyngaert, Zoe ^{[1
]}

Ledraa, Tounes ^{[1
]}

Belhocine, Ramdane ^{[1
]}

Sestili, Simona ^{[1
]}

Lapusan, Simona ^{[1
]}

Hirsch, Pierre ^{[3
,4
,6
]}

Favale, Fabrizia ^{[3
,4
,6
]}

Boussaroque, Agathe ^{[3
,4
,6
]}

Bonnin, Agnes ^{[1
]}

Vekhoff, Anne ^{[1
]}

Legrand, Ollivier ^{[1
,3
,4
]}

Mohty, Mohamad ^{[1
,3
,4
]}

Dulery, Remy ^{[1
,3
,4
]}

机构：

[1] St Antoine Hosp, AP HP, Dept Hematol & Cellular Therapy, 184 Rue Faubourg St Antoine, F-75012 Paris, France

[2] Univ Naples Federico II, Hematol & Hematopoiet Stem Cell Transplant Ctr, Dept Med & Surg, Naples, Italy

[3] INSERM, UMRs 938, Paris, France

[4] Sorbonne Univ, Hop St Antoine, AP HP, Paris, France

[5] Univ Pavia, Dept Mol Med, Pavia, Italy

[6] Hop St Antoine, AP HP, Serv Hematol Biol, Paris, France

来源：

LEUKEMIA & LYMPHOMA | 2021年 / 62卷 / 02期

关键词：

Thiotepa; busulfan; fludarabine; HSCT; TBF; myelofibrosis; STEM-CELL TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; LEUKEMIA WORKING PARTY; HAPLOIDENTICAL TRANSPLANTATION; EUROPEAN-SOCIETY; RISK-FACTORS; MARROW; SPLENECTOMY; RUXOLITINIB; MANAGEMENT;

D O I：

10.1080/10428194.2020.1827246

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We assessed the outcomes associated with thiotepa, busulfan and fludarabine (TBF) conditioning regimen in a cohort of 29 consecutive patients allografted for myelofibrosis (MF). The median age was 56 (range 42-70) years. According to the refined Dynamic International Prognostic Scoring System (DIPSS-plus), 15 (52%) patients were classified as high risk. Graft source was peripheral blood stem cells in 27 patients. Donor type was HLA-matched related (n = 5), matched unrelated (n = 16), mismatched unrelated (n = 1), and haploidentical (n = 7). All but 2 patients engrafted. The cumulative incidence (CI) of grade II-IV acute graft-versus-host disease (GVHD) was 21% (95% CI, 10-42) at day 100. The CI of chronic GVHD was 39% (95% CI, 23-65) at 3 years. The median follow-up period was 39 (range 14-60) months. Overall survival was 69% (95% CI, 50-83) at 3 years. No relapse was observed. TBF is a valid conditioning strategy in patients with MF.

引用

页码：419 / 427

页数：9

共 50 条

[21] Busulfan with fludarabine myeloablative conditioning regimen in myeloid neoplasms: A single center experience.
Raj, Renju V.
Button, Anna M.
Dozeman, Lindsay
De Magalhaes-Silverman, Margarida
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[22] Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis
Yamamoto, Wataru
Andou, Taiki
Itabashi, Megumi
Koyama, Satoshi
Ishii, Yoshimi
Numata, Ayumi
Motohashi, Kenji
Hagihara, Maki
Matsumoto, Kenji
Fujisawa, Shin
INTERNAL MEDICINE, 2016, 55 (13) : 1721 - 1727
[23] Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
Bornhäuser, M
Storer, B
Slattery, JT
Appelbaum, FR
Deeg, HJ
Hansen, J
Martin, PJ
McDonald, GB
Nichols, WG
Radich, J
Woolfrey, A
Jenke, A
Schleyer, E
Thiede, C
Ehninger, G
Anasetti, C
BLOOD, 2003, 102 (03) : 820 - 826
[24] OUTCOME OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING (FLUDARABINE/MELPHALAN/ATG) CONDITIONING: SINGLE CENTER EXPERIENCE
Ibraheem, Abousoudah Faisal
MuayadMamdooh, Alali
Alam, Muhammad Matloob
Salaheldin, Bayoumy Mohamed
PEDIATRIC BLOOD & CANCER, 2015, 62 : S8 - S8
[25] Treatment of Hemophagocytic Lymphohistiocytosis with Allogeneic Hematopoietic Stem Cell Transplantation Using the Conditioning Regimen with Busulfan and Fludarabine: A Single-Center Study of 38 Cases
Sun, Yuan
Xiao, Juan
Fan, Shifen
Liu, Zhouyang
Xu, Fei
Zhang, Lei
Jiang, Fan
Liu, Xiaomei
PEDIATRIC BLOOD & CANCER, 2016, 63 : S52 - S53
[26] Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders
Fraser, Ally
Castillo, Paul
Cascio, Erika
Moore-Higgs, Giselle
Farhadfar, Nosha
Fort, John
Slayton, William
Lamba, Jatinder
Horn, Biljana
PEDIATRIC BLOOD & CANCER, 2023, 70 (07)
[27] Thiotepa-based conditioning regimens in allogeneic hematopoietic stem cell transplantation for patients with myelofibrosis
Dulery, R.
Giannotti, F.
Battipaglia, G.
Ruggeri, A.
Brissot, E.
Malard, F.
Sestili, S.
Belhocine, R.
Vekhoff, A.
Gueye, M. S.
Lapusan, S.
Adaeva, R.
Isnard, F.
Legrand, O.
Mohty, M.
BONE MARROW TRANSPLANTATION, 2017, 52 : S337 - S337
[28] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
Dai, Zhiming
Liu, Jie
Zhang, Wang-Gang
Cao, Xingmei
Zhang, Yang
Dai, Zhijun
MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
[29] Efficacy of treosulfan in combination with fludarabine as conditioning regimen in allogeneic transplantation as compared with a myeloablative conditioning using busulfan and fludarabine
Calvo Sanchez, J. A.
Fernandez Garcia, S.
Aranguren del Castillo, L.
Fernandez-Luis, S.
Yanez San Segundo, L.
Insunza Gaminde, A.
Fernandez Escalada, N.
Martin Sanchez, G.
Colorado Araujo, M. M.
Lopez Duarte, M.
Sanchez Escamilla, M.
Montes Gaisan, C.
Romon Alonso, J. I.
Arroyo Rodriguez, J. L.
Ocio San Miguel, E. M.
Bermudez Rodriguez, M. A.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 166 - 167
[30] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS: SINGLE CENTER EXPERIENCE
Nishihori, T.
Perkins, J.
Pidala, J.
Roman, J.
Kim, J.
Fernandez, H.
Anasetti, C.
Kharfan-Dabaja, M. A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S293 - S293

← 1 2 3 4 5 →